Literature DB >> 18090589

Thymoma-associated graft-versus-host disease-like erythroderma.

Tomoyuki Nakagiri1, Meinoshin Okumura, Masayoshi Inoue, Masato Minami, Eiji Kiyohara, Noriko Umegaki, Toshiaki Nakamura, Yasuhiko Tomita, Ichirou Katayama, Katsuyuki Aozasa.   

Abstract

We report a 40-year-old woman with recurrent thymoma associated with myasthenia gravis, in whom an unusual form of erythroderma developed. A histological examination revealed a graft-versus-host disease (GVHD)-like reaction. After high-dose steroid therapy, the metastatic thymoma lesion in the abdominal cavity was reduced in size from 9.5 x 6 x 7.5 cm to 4 x 3 x 1 cm in diameter. Nevertheless, the GVHD-like erythroderma become aggravated, her condition worsened, and the patient finally suffered from respiratory failure and died of sepsis. A GVHD-like reaction may be a rare presentation of thymoma-associated immunological disorders such as myasthenia gravis or pure red cell aplasia. Herein, we discuss the present case and review pertinent reports of thymoma cases associated with GVHD.

Entities:  

Mesh:

Year:  2007        PMID: 18090589     DOI: 10.1097/JTO.0b013e31815ba23a

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.

Authors:  T Hanafusa; H Azukizawa; S Kitaba; H Murota; N Umegaki; M Terao; S Sano; T Nakagiri; M Okumura; I Katayama
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Undifferentiated pleiomorphic sarcoma simultaneously occuring with thymoma.

Authors:  Christos Simoglou; Nikolaos Tsolakis
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

Review 3.  Chemotherapy improves thymoma-associated graft-versus-host-disease-like erythroderma.

Authors:  Tatsuya Nagano; Yoshikazu Kotani; Kazuyuki Kobayashi; Nanako Tomita; Kyosuke Nakata; Akihiro Sakashita; Yasuhiro Funada; Hiroshi Nagai; Tomoo Itoh; Yoshihiro Nishimura
Journal:  BMJ Case Rep       Date:  2011-05-10

Review 4.  Thymic tumours: a single center surgical experience and literature review on the current diagnosis and management of thymic malignancies.

Authors:  Fabrizio Minervini; Laura Boschetti; Michael Gregor; Mariano Provencio; Virginia Calvo; Peter B Kestenholz; Savvas Lampridis; Davide Patrini; Pietro Bertoglio; L Filipe Azenha; Consolato M Sergi; Gregor J Kocher
Journal:  Gland Surg       Date:  2021-11

5.  Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity.

Authors:  Hiroo Kasahara; Kazuki Shimizu; Kouki Makioka; Takaaki Sano; Yoichi Ohtaki; Yoshio Ikeda
Journal:  Immunol Res       Date:  2022-03-14       Impact factor: 2.829

6.  Graft-versus-host disease-like erythroderma: a manifestation of thymoma-associated multiorgan autoimmunity.

Authors:  Shay Warren; Kishwer Nehal; Christiane Querfeld; Richard Wong; James Huang; Melissa Pulitzer
Journal:  J Cutan Pathol       Date:  2015-10       Impact factor: 1.587

Review 7.  Thymus, thymoma and myasthenia gravis.

Authors:  Yoshitaka Fujii
Journal:  Surg Today       Date:  2012-09-05       Impact factor: 2.549

Review 8.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

9.  SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.

Authors:  Federica Giugliano; Paolo A Zucali; Giulia Galli; Zelmira Ballatore; Chiara Corti; Pamela T Aliaga; Jacopo Uliano; Grazia Vivanet; Giuseppe Curigliano; Fabio Conforti; Paola Queirolo; Rossana Berardi; Sara Manglaviti; Giulia Apollonio; Matteo Perrino; Federica Borea; Federica D'Antonio; Marina C Garassino; Tommaso De Pas
Journal:  Eur J Cancer       Date:  2022-02-25       Impact factor: 10.002

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.